Why inventing a vaccine for AIDS is tougher than for COVID

By NPR
| January 26, 2023

The four-decades long effort to create an HIV vaccine suffered a blow last week with news that Janssen Pharmaceuticals was discontinuing the only current late-stage clinical trial of a vaccine. Results showed it to be ineffective.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...